Invention Application
- Patent Title: EGFR INHIBITORS, COMPOSITIONS AND METHODS THERE OF
-
Application No.: US17439324Application Date: 2020-03-31
-
Publication No.: US20220227796A1Publication Date: 2022-07-21
- Inventor: Xiangyong LIU , Changyong QIU , Qichao SHEN , Mengqiang LIU , Haitong SHENG , Guolong DU , Jiabing WANG , Lieming DING
- Applicant: Betta Pharmaceuticals Co., Ltd.
- Applicant Address: CN Zhejiang
- Assignee: Betta Pharmaceuticals Co., Ltd.
- Current Assignee: Betta Pharmaceuticals Co., Ltd.
- Current Assignee Address: CN Zhejiang
- Priority: CNPCT/CN2019/081615 20190404,CNPCT/CN2019/081616 20190404,CNPCT/CN2019/081617 20190404,CNPCT/CN2019/081618 20190404
- International Application: PCT/CN2020/082347 WO 20200331
- Main IPC: C07F9/6512
- IPC: C07F9/6512 ; C07F9/6561 ; A61P35/00
Abstract:
The present invention relates to compounds of Formula I, methods of using the compounds as EGFR inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Information query
